Puskarich, M. A., Jennaro, T. S., Gillies, C. E., Evans, C. R., Karnovsky, A., McHugh, C. E., . . . Investigators, f. t. R. (2021). Pharmacometabolomics identifies candidate predictor metabolites of an L‐carnitine treatment mortality benefit in septic shock. Wiley.
Cita Chicago Style (17a ed.)Puskarich, Michael A., et al. Pharmacometabolomics Identifies Candidate Predictor Metabolites of an L‐carnitine Treatment Mortality Benefit in Septic Shock. Wiley, 2021.
Cita MLA (8a ed.)Puskarich, Michael A., et al. Pharmacometabolomics Identifies Candidate Predictor Metabolites of an L‐carnitine Treatment Mortality Benefit in Septic Shock. Wiley, 2021.
Precaución: Estas citas no son 100% exactas.